EUVIMEDEUVIMED entdecken
Crossref

Information Disclosure and Competitive Dynamics: Evidence from the Pharmaceutical Industry

Jennifer Kao

Management Science · 2025-07 · 71 (7) · 5948-5970

DOI: 10.1287/mnsc.2022.01161 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Management Science, 2025-07. Verfasst von Jennifer Kao. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 105 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This paper studies how competitive dynamics shape innovative firms’ voluntary disclosure of product quality information. Our empirical context is the pharmaceutical industry, where firms must decide whether to disclose private drug quality information acquired in clinical trials. Using a difference-in-difference strategy, we show that the approval of a competitor’s drug lowers the likelihood of a firm reporting its clinical trial results by 13%. We explore how these effects vary based on the project quality, competitor type, and firm experience. These findings suggest that strategic considerations play a role in firms’ disclosure decisions; in response to a competitor’s drug approval, firms may selectively withhold information to maintain and improve their competitive position. This paper was accepted by Joshua Gans, business strategy. Funding: This work was funded by the National Institute on Aging [Grant T32-AG000186] and the UCLA Society of Hellman Fellows Program. Supplemental Material: The online appendix and data files are available at https://doi.org/10.1287/mnsc.2022.01161 .

Zitieren

APA

Kao, J. (2025). Information Disclosure and Competitive Dynamics: Evidence from the Pharmaceutical Industry. Management Science, 71(7), 5948-5970. https://doi.org/10.1287/mnsc.2022.01161

Vancouver

Kao J. Information Disclosure and Competitive Dynamics: Evidence from the Pharmaceutical Industry. Management Science. 2025;71(7):5948-5970. doi:10.1287/mnsc.2022.01161

BibTeX
@article{Kao2025,
  author = {Kao, Jennifer},
  title = {Information Disclosure and Competitive Dynamics: Evidence from the Pharmaceutical Industry},
  journal = {Management Science},
  year = {2025},
  volume = {71},
  number = {7},
  pages = {5948--5970},
  doi = {10.1287/mnsc.2022.01161}
}
Kostenlos starten →